Petershill Partners PLC (LON:PHLL – Get Free Report) hit a new 52-week high on Monday . The stock traded as high as GBX 209.38 ($2.63) and last traded at GBX 208.50 ($2.62), with a volume of 795333 shares changing hands. The stock had previously closed at GBX 208 ($2.61).
Analysts Set New Price Targets
PHLL has been the subject of several research reports. JPMorgan Chase & Co. increased their price objective on Petershill Partners from GBX 247 ($3.10) to GBX 256 ($3.22) and gave the company an “overweight” rating in a report on Friday, April 5th. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 200 ($2.51) price target on shares of Petershill Partners in a report on Wednesday, March 27th.
Check Out Our Latest Analysis on PHLL
Petershill Partners Stock Down 0.5 %
Petershill Partners Increases Dividend
The business also recently declared a dividend, which will be paid on Friday, June 14th. Stockholders of record on Thursday, May 9th will be issued a $0.10 dividend. This is a positive change from Petershill Partners’s previous dividend of $0.05. This represents a dividend yield of 4.63%. The ex-dividend date of this dividend is Thursday, May 9th. Petershill Partners’s dividend payout ratio (DPR) is presently 130,000.00%.
Petershill Partners Company Profile
Petershill Partners PLC operates as a general partner solutions investment firm. It provides capital and strategic support to asset managers through minority stake acquisitions. The company was formerly known as Delta Epsilon plc and changed its name to Petershill Partners PLC in September 2, 2021. The company was founded in 2007 and is based in London, the United Kingdom.
Read More
- Five stocks we like better than Petershill Partners
- What is the Shanghai Stock Exchange Composite Index?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Hilton Demonstrates Asset Light is Right for Investors
- Profitably Trade Stocks at 52-Week Highs
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Petershill Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petershill Partners and related companies with MarketBeat.com's FREE daily email newsletter.